Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest CARIS Stories

2014-03-28 08:26:18

IRVING, Texas, March 28, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, continues to enhance its industry-leading comprehensive tumor profiling service, Caris Molecular Intelligence(TM), now capable of providing an industry-leading 51 drug target associations, including exciting new immunologically-based drug targets. Through these enhancements, Caris Molecular Intelligence will now provide...

2014-02-21 08:25:07

IRVING, Texas, Feb. 21, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced that former President George W. Bush, the 43(rd )President of the United States, was the featured keynote speaker at its annual sales meeting held in Phoenix, Ariz., this week. President Bush's remarks were featured as part of a conversation between the President and David D. Halbert, Chairman and CEO of Caris Life...

2014-01-18 08:20:15

Research findings enable disease molecular sub-typing to lead to more informed clinical decision-making IRVING, Texas, Jan. 18, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer (CRC) at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by...

2013-12-19 08:27:24

IRVING, Texas, Dec. 19, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, has announced that its tumor profiling laboratory, located in Phoenix, Ariz., has obtained the molecular profiling industry's first-ever accreditation to the International Standards Organization (ISO) 15189 "Medical laboratories - Requirements for quality and competence," accredited by the American Association for Laboratory...

2013-12-17 08:29:11

Latest Award Further Demonstrates Company's Established International Intellectual Property Position IRVING, Texas, Dec. 17, 2013 /PRNewswire/ -- Caris Life Sciences(®), a leading biosciences company focused on fulfilling the promise of personalized medicine, has been granted a patent in The People's Republic of China covering its molecular profiling service, Caris Molecular Intelligence(TM), for cancer patients. China represents a large population of unmet medical need, with...

2013-11-14 08:33:06

Findings further demonstrate the validity of a multiple-technology approach to tumor profiling for cancer patients IRVING, Texas, Nov. 14, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present five tumor profiling studies at the 2013 Annual Meeting of the Association for Molecular Pathology (AMP), held this week in Phoenix, Ariz. Results were obtained using Caris' comprehensive tumor profiling...

2013-08-22 08:26:42

Expansion offers key international markets innovative, thorough biomarker analysis to improve care for cancer patients IRVING, Texas, Aug. 22, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence(TM), in select Middle Eastern and African markets. Given...

2013-06-02 08:20:14

Analysis of world's largest commercial cancer patient database uncovers clinically actionable targets IRVING, Texas, June 2, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, will present findings today at the 2013 ASCO annual meeting from the analysis of its Caris Molecular Intelligence(TM) database. This database examined the results of molecular profiling of both common and rare cancer types for...

2013-05-31 08:24:11

Supplementary Genomic Analysis Will Offer Complement to Best-in-Class Molecular Profiling Clinical Tool IRVING, Texas, May 31, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced it intends to expand its Next-Generation Sequencing (NGS) capabilities to include whole exome and transcriptome sequencing. The offering will provide physicians with an in-depth report focusing on the 452...

2013-05-29 08:30:28

Evidence-Guided Molecular Profiling Services will be featured in three separate data presentations IRVING, Texas, May 29, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced that three data presentations on Caris Molecular Intelligence(TM), the world's foremost, evidence-guided molecular profiling service, will take place this weekend at the 2013 annual meeting of the American Society...